The APO‐1/Fas (CD95) receptor is expressed in homozygous MRL/lpr mice

Authors:

Abstract
APO‐1/Fas (CD95) is a transmembrane receptor that transduces apoptotic signals within various cells including T and B cells. The APO‐1 gene was found to be defective in lpr mice. In these mice insertion of a retrotransposon gives rise to transcription of an abnormal mRNA and only a fraction of wild‐type APO‐1 mRNA. It is not clear if lpr mice still express wild‐type APO‐1 protein. To address this question, we prepared rabbit anti‐APO‐1 antibodies (Ab) with a peptide representing the extracellular sequence corresponding to residues 5‐23 of APO‐1. The rabbit Ab reacted with thymocytes from different mouse strains and the extent of binding was correlated with the two known APO‐1 alleles. In addition, the Ab reacted with mouse cell lines expressing mouse APO‐1 mRNA but not with human cell lines. Binding of the Ab to MRL and BALB/c thymocytes was completely blocked by the immunizing peptide. Immunofluorescence analysis of MRL/lpr thymocytes showed that they still express APO‐1 protein at approximately one tenth of the wild‐type expression level on their surface. In addition, in lpr as in wild‐type mice we found a decrease of APO‐1 expression in the more mature thymic compartment. Western blot analysis of whole cell lysates from lpr and wild‐type thymocytes showed that the Ab recognized APO‐1 in both cell types. Approximately 50% of CD3+ splenocytes and 80% of in vitro activated CD3+ cells from wild‐type mice reacted with the Ab, but to a lower extent than thymocytes. The same differential reactivity was found in lpr CD3+ splenocytes. lpr T cells, however, showed a substantially lower level of APO‐1. Thus, the differential expression of APO‐1 on thymic versus peripheral lpr T cells might influence their sensitivity towards APO‐1‐mediated apoptosis.

This publication has 21 references indexed in Scilit: